期刊文献+

Adenovirus-mediated PTEN gene transfection suppresses growth and promotes chemosensitivity of endometrial carcinoma

Adenovirus-mediated PTEN gene transfection suppresses growth and promotes chemosensitivity of endometrial carcinoma
下载PDF
导出
摘要 Objective: To determine the potential of sustained transgene expression by intratumoral injection of Ad-PTEN in the nude mouse model of endometrial carcinoma. Methods and Results: We constructed recombinant adenovirus carrying the wild-type PTEN gene (Ad-PTEN). RL95-2 cells, an endometrial carcinoma cell line lacking PTEN function, was infected with Ad-PTEN and showed increased expression of PTEN and chemosensitivity to doxorubicin, decreased proliferation rate, and elevated apoptosis and Go/G1 arrest. Furthermore, the tumorigenicity of these cells was also completely suppressed. These results indicated that gene therapy with Ad-PTEN could significantly inhibit the endometrial carcinoma xenografts growth in nude mice by intratumoral injection, induce apoptosis of tumor cells, and reduce expression of proliferating cell nuclear antigen (PCNA). Immunohistochemistry analysis also showed that the expression of progesterone receptors (PR) in Ad-PTEN treated tumor cells were induced, while P-glycoproteins (P-gp) and estrogen receptors (ER) decreased significantly. Conclusion: PTEN may play an important role in the development of endometrial carcinoma. Our findings cast new lights for treatment ofendometrial carcinoma. Objective:To determine the potential of sustained transgene expression by intratumoral injection of Ad-PTEN in the nude mouse model of endometrial carcinoma.Methods and Results:We constructed recombinant adenovirus carrying the wild-type PTEN gene(Ad-PTEN).RL95-2 cells,an endometrial carcinoma cell line lacking PTEN function,was infected with Ad-PTEN and showed increased expression of PTEN and chemosensitivity to doxorubicin,decreased proliferation rate,and elevated apoptosis and G0/G1 arrest.Furthermore,the tumorigenicity of these cells was also completely suppressed.These results indicated that gene therapy with Ad-PTEN could significantly inhibit the endometrial carcinoma xenografts growth in nude mice by intratumoral injection,induce apoptosis of tumor cells,and reduce expression of proliferating cell nuclear antigen(PCNA).Immunohistochemistry analysis also showed that the expression of progesterone receptors(PR) in Ad-PTEN treated tumor cells were induced,while P-glycoproteins(P-gp) and estrogen receptors(ER) decreased significantly.Conclusion:PTEN may play an important role in the development of endometrial carcinoma.Our findings cast new lights for treatment of endometrial carcinoma.
出处 《Journal of Medical Colleges of PLA(China)》 CAS 2010年第4期193-203,共11页 中国人民解放军军医大学学报(英文版)
基金 Supported by the National Natural Science Foundation of China(30471676) Shanghai Science and Technology Committee(04DZ19207-2)
关键词 Endometrial carcinoma Gene therapy CHEMOSENSITIVITY Apoptosis PTEN基因 子宫内膜癌 腺病毒介导 抑制生长 基因转染 敏感性 肿瘤细胞凋亡 细胞增殖率
  • 相关文献

参考文献19

  • 1Shiozawa T, Konishi I. Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment. Int J Clin Oncol 2006; 11: 13-21.
  • 2Anderson PR. The role of radiation therapy in locally advanced endometrial cancer.Semin Radiat Oncol 2006; 16: 152-157.
  • 3Barlin JN, advanced Puri I, Bristow RE.Cytoreductive surgery for or recurrent endometrial cancer: a meta-analysis.Gynecol Oncol 2010 Jul; 118:14-18.
  • 4Horn LC, Dietel M, Einenkel J. Hormone replacement therapy (HRT) and endometrial morphology under consideration of the different molecular pathways in endometrial carcinogenesis. Eur J Obstet Gynecol Reprod Biol 2005; 122: 4-12.
  • 5Beral V, Bull D, Reeves G. Million Women Study Collaborators. Endometrial cancer and hormone- replacement therapy in the Million Women Study. Lancet 2005; 365: 1543-1551.
  • 6Despierre E, Moerman P, Vergote I, et al. Is there a role for neoadjuvant chemotherapy in the treatment of stage IV serous endometrial carcinoma? Int J Gynecol Cancer 2006; 16: 273-277.
  • 7Zhu Y, Hoell P, Ahlemeyer B, et al. PTEN: a crucial mediator of mitochondria-dependent apoptosis. Apoptosis 2006;11:197-207.
  • 8Okuda T, Sekizawa A, Purwosunu Y, et al. Genetics of endometrial cancers. Obstet Gynecol Int 2010; 2010: 984013. Epub 2010 Apr 8.
  • 9Zheng T, Meng X, Wang J, et al PTEN- and p53- mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice. J Cell Biochem 2010 [Epub ahead of print].
  • 10Konopka B, Paszko Z, Janiec-Jankowska A, et al. Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias. Cancer Lett 2002; 178:43-51.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部